Aims and objectives. The aim of this paper was to develop an understanding of the factors involved in older people's decision making with regard to influenza vaccination to inform strategies to improve vaccine uptake and reduce morbidity and mortality. Background. Influenza is a major cause of morbidity and mortality world-wide. In the UK, it accounts for 3000–6000 deaths annually; 85% of these deaths are people aged 65 and over. Despite this, and the widespread and costly annual government campaigns, some older people at risk of influenza and the associated complications remain reluctant to take advantage of the offer of vaccination. Methods. A review of the English language literature referring to older people published between 1996...
BACKGROUND: The effectiveness of influenza vaccination against hospitalization and death can only et...
Introduction: Influenza vaccination is the most effective method of preventing influenza infection i...
BACKGROUND: Although influenza immunisation is now recommended for all people aged 65 years and over...
Backgrounds: Receive seasonal influenza vaccination is the most safe and effective way to prevent ...
The objective of this qualitative study was to explore the factors that influence community dwelling...
Background: Although the burden of influenza infection is the highest in older adults, vaccination c...
peer-reviewedBackground Despite many government initiatives, uptake of the trivalent influenza vacci...
Influenza, pneumococcal disease, and shingles (herpes zoster) are more prevalent in older people. Th...
Many older people who would benefit from influenza vaccine do not get immunised. We carried out a po...
In a recent review the effectiveness of influenza vaccination in the elderly was brought into questi...
Background/objectivesDespite influenza vaccination programs in various jurisdictions, seasonal influ...
Objective: To present the results of a literature review on factors related to vaccine uptake by eld...
Influenza, pneumococcal disease, and shingles are more prevalent in older people, with this group ha...
Background: Surveys of older adults\u2019 knowledge relative to flu immunization have highlighted it...
BACKGROUND: Although influenza immunisation is now recommended for all people aged 65 years and over...
BACKGROUND: The effectiveness of influenza vaccination against hospitalization and death can only et...
Introduction: Influenza vaccination is the most effective method of preventing influenza infection i...
BACKGROUND: Although influenza immunisation is now recommended for all people aged 65 years and over...
Backgrounds: Receive seasonal influenza vaccination is the most safe and effective way to prevent ...
The objective of this qualitative study was to explore the factors that influence community dwelling...
Background: Although the burden of influenza infection is the highest in older adults, vaccination c...
peer-reviewedBackground Despite many government initiatives, uptake of the trivalent influenza vacci...
Influenza, pneumococcal disease, and shingles (herpes zoster) are more prevalent in older people. Th...
Many older people who would benefit from influenza vaccine do not get immunised. We carried out a po...
In a recent review the effectiveness of influenza vaccination in the elderly was brought into questi...
Background/objectivesDespite influenza vaccination programs in various jurisdictions, seasonal influ...
Objective: To present the results of a literature review on factors related to vaccine uptake by eld...
Influenza, pneumococcal disease, and shingles are more prevalent in older people, with this group ha...
Background: Surveys of older adults\u2019 knowledge relative to flu immunization have highlighted it...
BACKGROUND: Although influenza immunisation is now recommended for all people aged 65 years and over...
BACKGROUND: The effectiveness of influenza vaccination against hospitalization and death can only et...
Introduction: Influenza vaccination is the most effective method of preventing influenza infection i...
BACKGROUND: Although influenza immunisation is now recommended for all people aged 65 years and over...